$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
抗癌靶向药物博舒替尼属于第几代靶向药物?有什么作用?
2025-10-19 11:44:20
Check Details
分析发现复发/难治性慢性淋巴细胞白血病患者对BTK抑制剂的耐药性机制
2025-10-19 11:44:20
Check Details
低甲基化药物+维奈克拉片一线治疗继发性急性髓系白血病可提高疗效
2025-10-19 11:44:20
Check Details
FDA授予艾伏尼布/阿扎胞苷优先审查资格,用于IDH1突变型急性髓系白血病
2025-10-19 11:44:20
Check Details
维奈克拉片venetoclax提供了一个全新的治疗希望
2025-10-19 11:44:20
Check Details
国内哪里能买到维奈克拉片venetoclax?能用医保报销吗
2025-10-19 11:44:20
Check Details
米哚妥林治疗白血病的效果好吗?治疗期间有哪些副作用
2025-10-19 11:44:20
Check Details
基石药业艾伏尼布中国新药上市申请已获NMPA受理
2025-10-19 11:44:20
Check Details
米哚妥林Midostaurin的推荐剂量是多少?要注意什么
2025-10-19 11:44:20
Check Details
艾伏尼布多少钱?南京在哪里可以购买到?
2025-10-19 11:44:20
Check Details
普纳替尼Ponatinib会耐药吗?治疗期间要注意什么
2025-10-19 11:44:20
Check Details
普纳替尼Ponatinib国内能买到吗?多少钱一盒
2025-10-19 11:44:20
Check Details
1
2
...
647
648
649
650
651
652
653
...
933
934
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Avatrombopag vs Hetrombopag: Full Comparison of TPO Receptor Agonists for Thrombocytopenia
2
Kresladi Approved by FDA: First Gene Therapy for Severe LAD-I
3
Pegcetacoplan Side Effects and Medication Safety Complete Guide
4
Pegcetacoplan (Empaveli): Complete Guide to PNH Complement Inhibitor Treatment
5
Eltrombopag: Innovative TPO Receptor Agonist for Treating Thrombocytopenia - Comprehensive Drug Analysis
6
Is MDS Targeted Therapy Chemotherapy? Mechanism, Genetic Testing, and Personalized Care Guide
7
Enasidenib Targeted Therapy Guide: IDH2 Mutant AML Patient Medication Details
8
Anagrelide Medication Guide: Dosage, Efficacy and Side Effects Explained
9
Romiplostim vs. Eltrombopag: ITP Treatment Dosing Differences and Precision Selection
10
Asciminib: Mechanism and Clinical Value of the First ABL Allosteric Inhibitor
11
Does Ixazomib (Ninlaro) Require Long-Term Use to Be Effective?
12
What is the effectiveness of the new weapon for myeloma patients: cetuximab? Listen to what the user has to say